We are honoured to announce that we have joined forces with the European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) to bring together expert Hepatologists and Nephrologists to eliminate viral hepatitis among patients with chronic kidney disease (CKD).
Professor Michel Jadoul, who is jointly leading this initiative with Professor Stanislas Pol, said “The burden associated with HCV (mortality, morbidity and quality of life) remains substantial in CKD, dialysis and kidney transplant patients . Fortunately, very recent studies extend the dramatic improvement of the treatment of hepatitis C to CKD populations . Thus, there should be no reason for complacency anymore. Success is now at hand, under the partnership of key actors in the field of liver and kidney diseases.”
The initiative will kick-off on November 1st in conjunction with the Kidney Week Meeting in New Orleans. Together, we aim to not only kick-start the call to action but provide the information, training, tools, and strategic guidance to radically alter the prevention and treatment of viral hepatitis in this vulnerable population.